Skip to content
Agentic OS
Menu

Intelligence / Healthtech / New Clinical Trials / Hamad Medical Corporation

Clinicaltrial registered28 Oct 2026

Hamad Medical Corporation

28 Oct 2026: Trial registered · Middle East Study of Infections in Patients With Hematological Malignancies. Recorded in the ClinicalTrials.gov (US National Library of Medicine).

View the source record

Posted
28 Oct 2026
Title
Middle East Study of Infections in Patients With Hematological Malignancies
Conditions
Hematological Malignancy, Hematopoetic Stem Cell Transplantation, Bloodstream Infection
Study Type
Observational
Status
Recruiting
Countries
Jordan, Oman, Qatar, Saudi Arabia, United Arab Emirates
Country
Jordan
Reference
NCT07900542
Location
Jordan, Oman, Qatar
What this signal means

A new trial needs sites, patients, data capture, monitoring and regulatory partners for years.

  1. United States leads with 192 of 777, then China (171).
  2. 777 added in the 30 days to 18 Nov 2026.
Reach them with AOS

Find the decision makers at Hamad Medical Corporation

AOS maps the buying committee, finds verified work emails and drafts outreach that cites this clinical signal, for your approval.

Start free

Across AOS Research

Other records for Hamad Medical Corporation in our registers.

More from Jordan

New Clinical Trials

See all

Source: ClinicalTrials.gov (US National Library of Medicine), data to 18 Nov 2026. Trials first posted in the window whose lead sponsor is a company, worldwide. Device and diagnostic studies usually have no phase. AOS shows what the public record says; it does not verify or endorse the company.